Suppr超能文献

肝硬化和 MELD 评分对肝切除患者术后发病率和死亡率的影响。

The impact of cirrhosis and MELD score on postoperative morbidity and mortality among patients selected for liver resection.

机构信息

Department of Surgery, University of Virginia, Charlottesville, VA, USA; Surgical Outcomes Research Center, University of Virginia, Charlottesville, VA, USA; Section of Hepatobiliary and Pancreatic Surgery, University of Virginia, Charlottesville, VA, USA.

Department of Surgery, University of Virginia, Charlottesville, VA, USA; Surgical Outcomes Research Center, University of Virginia, Charlottesville, VA, USA.

出版信息

Am J Surg. 2020 Sep;220(3):682-686. doi: 10.1016/j.amjsurg.2020.01.022. Epub 2020 Jan 20.

Abstract

BACKGROUND

Independent associations between chronic liver disease, MELD, and postoperative outcomes among patients selected for liver resection have not been completely established. We hypothesized independent associations between MELD, cirrhosis, and postoperative mortality.

METHODS

Patient-level data from the targeted hepatectomy module and ACS NSQIP PUF during 2014-2015 were merged. Multivariable regression models with interaction effect between MELD and liver texture (normal, congested/fatty, cirrhotic) tested the independent effects of covariates on mortality and morbidity.

RESULTS

3,530 patients were included, of whom 668 patients (19%) had cirrhosis. ACS NSQIP defined mortality (3.9%vs1.1%) and morbidity (23.5%vs15.8%) were higher in patients with cirrhosis (both p < 0.001). In multivariable models, cirrhosis (OR = 2.24; 95%CI:1.16-4.34, p = 0.016) and MELD (OR = 1.10; 95%CI:1.03-1.18, p = 0.007) were independently associated with mortality. MELD (OR = 1.04; 95%CI:1.002-1.08, p = 0.038) was associated with postoperative morbidity.

CONCLUSIONS

Higher MELD and presence of cirrhosis have an independent negative effect on mortality after liver resection. MELD could be used to estimate postoperative risk in patients with and without cirrhosis.

摘要

背景

慢性肝病、MELD 评分和肝切除术患者术后结局之间的独立关联尚未完全确定。我们假设 MELD、肝硬化与术后死亡率之间存在独立关联。

方法

合并了 2014-2015 年靶向肝切除术模块和 ACS NSQIP PUF 的患者水平数据。多变量回归模型中,MELD 与肝脏质地(正常、充血/脂肪、肝硬化)之间存在交互效应,用于测试协变量对死亡率和发病率的独立影响。

结果

共纳入 3530 例患者,其中 668 例(19%)患有肝硬化。ACS NSQIP 定义的死亡率(3.9%比 1.1%)和发病率(23.5%比 15.8%)在肝硬化患者中更高(均 p<0.001)。多变量模型中,肝硬化(OR=2.24;95%CI:1.16-4.34,p=0.016)和 MELD(OR=1.10;95%CI:1.03-1.18,p=0.007)与死亡率独立相关。MELD(OR=1.04;95%CI:1.002-1.08,p=0.038)与术后发病率相关。

结论

较高的 MELD 和肝硬化的存在对肝切除术后的死亡率有独立的负面影响。MELD 可用于估计有无肝硬化患者的术后风险。

相似文献

1
The impact of cirrhosis and MELD score on postoperative morbidity and mortality among patients selected for liver resection.
Am J Surg. 2020 Sep;220(3):682-686. doi: 10.1016/j.amjsurg.2020.01.022. Epub 2020 Jan 20.
2
Comparing Outcomes of Minimally Invasive and Open Hepatectomy for Primary Liver Malignancies in Patients with Low-MELD Cirrhosis.
J Gastrointest Surg. 2023 Nov;27(11):2424-2433. doi: 10.1007/s11605-023-05817-3. Epub 2023 Aug 24.
3
The impact of chronic liver disease on the risk assessment of ACS NSQIP morbidity and mortality after hepatic resection.
Surgery. 2016 May;159(5):1308-15. doi: 10.1016/j.surg.2015.11.020. Epub 2015 Dec 31.
6
Esophageal Cancer Surgery for Patients with Concomitant Liver Cirrhosis: A Single-Center Matched-Cohort Study.
Ann Surg Oncol. 2017 Mar;24(3):763-769. doi: 10.1245/s10434-016-5610-8. Epub 2016 Oct 4.
7
Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis.
J Hepatol. 2020 Jan;72(1):75-84. doi: 10.1016/j.jhep.2019.08.032. Epub 2019 Sep 6.
8
Model for End-Stage Liver Disease Sodium as a Predictor of Surgical Risk in Cirrhotic Patients With Ascites.
J Surg Res. 2020 Jun;250:45-52. doi: 10.1016/j.jss.2019.12.037. Epub 2020 Feb 1.
10
The utility of the MELD score in predicting mortality following liver resection for metastasis.
Eur J Surg Oncol. 2016 Oct;42(10):1568-75. doi: 10.1016/j.ejso.2016.05.035. Epub 2016 Jun 16.

引用本文的文献

1
Soluble TREM2 reflects liver fibrosis status and predicts postoperative liver dysfunction after liver surgery.
JHEP Rep. 2024 Oct 4;7(4):101226. doi: 10.1016/j.jhepr.2024.101226. eCollection 2025 Apr.
4
Predictors of Liver Failure in Non-Cirrhotic Patients Undergoing Hepatectomy.
World J Surg. 2022 Dec;46(12):3081-3089. doi: 10.1007/s00268-022-06742-3. Epub 2022 Oct 8.
5
Performance of risk prediction models for post-operative mortality in patients undergoing liver resection.
Am J Surg. 2023 Jan;225(1):198-205. doi: 10.1016/j.amjsurg.2022.07.028. Epub 2022 Aug 5.

本文引用的文献

2
Non-Hepatic Abdominal Surgery in Patients with Cirrhotic Liver Disease.
J Gastrointest Surg. 2019 Mar;23(3):634-642. doi: 10.1007/s11605-018-3991-7. Epub 2018 Nov 21.
3
Effects of patient factors on inpatient mortality after complex liver, pancreatic and gastric resections.
BJS Open. 2018 Mar 15;1(6):191-201. doi: 10.1002/bjs5.33. eCollection 2017 Dec.
5
The impact of chronic liver disease on the risk assessment of ACS NSQIP morbidity and mortality after hepatic resection.
Surgery. 2016 May;159(5):1308-15. doi: 10.1016/j.surg.2015.11.020. Epub 2015 Dec 31.
6
Morbidity and mortality of hepatectomy for benign liver tumors.
Am J Surg. 2016 Jan;211(1):102-8. doi: 10.1016/j.amjsurg.2015.06.010. Epub 2015 Jul 31.
7
A Systematic Review of Bariatric Surgery in Patients with Liver Cirrhosis.
Obes Surg. 2015 Aug;25(8):1518-26. doi: 10.1007/s11695-015-1727-2.
8
Mortality after cardiac surgery in patients with liver cirrhosis classified by the Child-Pugh score.
Interact Cardiovasc Thorac Surg. 2015 Apr;20(4):520-30. doi: 10.1093/icvts/ivu438. Epub 2015 Jan 22.
9
Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons.
J Am Coll Surg. 2013 Nov;217(5):833-42.e1-3. doi: 10.1016/j.jamcollsurg.2013.07.385. Epub 2013 Sep 18.
10
Predictors of morbidity and mortality after hepatectomy in elderly patients: analysis of 7621 NSQIP patients.
HPB (Oxford). 2014 May;16(5):459-68. doi: 10.1111/hpb.12155. Epub 2013 Aug 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验